BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Belisario DC, Kopecka J, Pasino M, Akman M, De Smaele E, Donadelli M, Riganti C. Hypoxia Dictates Metabolic Rewiring of Tumors: Implications for Chemoresistance. Cells 2020;9:E2598. [PMID: 33291643 DOI: 10.3390/cells9122598] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Rodriguez-Gonzalez JC, Hernández-Balmaseda I, Declerck K, Pérez-Novo C, Logie E, Theys C, Jakubek P, Quiñones-Maza OL, Dantas-Cassali G, Carlos Dos Reis D, Van Camp G, Lopes Paz MT, Rodeiro-Guerra I, Delgado-Hernández R, Vanden Berghe W. Antiproliferative, Antiangiogenic, and Antimetastatic Therapy Response by Mangiferin in a Syngeneic Immunocompetent Colorectal Cancer Mouse Model Involves Changes in Mitochondrial Energy Metabolism. Front Pharmacol 2021;12:670167. [PMID: 34924998 DOI: 10.3389/fphar.2021.670167] [Reference Citation Analysis]
2 Mansouri V, Beheshtizadeh N, Gharibshahian M, Sabouri L, Varzandeh M, Rezaei N. Recent advances in regenerative medicine strategies for cancer treatment. Biomed Pharmacother 2021;141:111875. [PMID: 34229250 DOI: 10.1016/j.biopha.2021.111875] [Reference Citation Analysis]
3 Akman M, Belisario DC, Salaroglio IC, Kopecka J, Donadelli M, De Smaele E, Riganti C. Hypoxia, endoplasmic reticulum stress and chemoresistance: dangerous liaisons. J Exp Clin Cancer Res 2021;40:28. [PMID: 33423689 DOI: 10.1186/s13046-020-01824-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
4 Mollaei M, Hassan ZM, Khorshidi F, Langroudi L. Chemotherapeutic drugs: Cell death- and resistance-related signaling pathways. Are they really as smart as the tumor cells? Transl Oncol 2021;14:101056. [PMID: 33684837 DOI: 10.1016/j.tranon.2021.101056] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Duś-Szachniewicz K, Gdesz-Birula K, Zduniak K, Wiśniewski JR. Proteomic-Based Analysis of Hypoxia- and Physioxia-Responsive Proteins and Pathways in Diffuse Large B-Cell Lymphoma. Cells 2021;10:2025. [PMID: 34440794 DOI: 10.3390/cells10082025] [Reference Citation Analysis]
6 Miro C, Nappi A, Cicatiello AG, Di Cicco E, Sagliocchi S, Murolo M, Belli V, Troiani T, Albanese S, Amiranda S, Zavacki AM, Stornaiuolo M, Mancini M, Salvatore D, Dentice M. Thyroid Hormone Enhances Angiogenesis and the Warburg Effect in Squamous Cell Carcinomas. Cancers (Basel) 2021;13:2743. [PMID: 34205977 DOI: 10.3390/cancers13112743] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Moreno C, Muñoz C, Terol MJ, Hernández-Rivas JÁ, Villanueva M. Restoration of the immune function as a complementary strategy to treat Chronic Lymphocytic Leukemia effectively. J Exp Clin Cancer Res 2021;40:321. [PMID: 34654437 DOI: 10.1186/s13046-021-02115-1] [Reference Citation Analysis]
8 Liu S, Washio J, Sato S, Abiko Y, Shinohara Y, Kobayashi Y, Otani H, Sasaki S, Wang X, Takahashi N. Rewired Cellular Metabolic Profiles in Response to Metformin under Different Oxygen and Nutrient Conditions. Int J Mol Sci 2022;23:989. [PMID: 35055173 DOI: 10.3390/ijms23020989] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Gao C, Kwong CH, Wang Q, Kam H, Wei J, Chen Q, Zhang J, Lee SM, Gu D, Wang R. Surface-engineered chlorella alleviated hypoxic tumor microenvironment for enhanced chemotherapy and immunotherapy of first-line drugs. Materials Today 2022. [DOI: 10.1016/j.mattod.2022.06.024] [Reference Citation Analysis]
10 He Q, Hao P, He G, Mai H, Liu W, Zhang W, Zhang K, Zhong G, Guo R, Yu C, Li Y, Wong C, Chen Q, Chen Y. IGF2BP1-regulated expression of ERRα is involved in metabolic reprogramming of chemotherapy resistant osteosarcoma cells. J Transl Med 2022;20:348. [PMID: 35918761 DOI: 10.1186/s12967-022-03549-7] [Reference Citation Analysis]
11 Xu R, Luo X, Ye X, Li H, Liu H, Du Q, Zhai Q. SIRT1/PGC-1α/PPAR-γ Correlate With Hypoxia-Induced Chemoresistance in Non-Small Cell Lung Cancer. Front Oncol 2021;11:682762. [PMID: 34381712 DOI: 10.3389/fonc.2021.682762] [Reference Citation Analysis]
12 Kopecka J, Salaroglio IC, Perez-Ruiz E, Sarmento-Ribeiro AB, Saponara S, De Las Rivas J, Riganti C. Hypoxia as a driver of resistance to immunotherapy. Drug Resist Updat 2021;:100787. [PMID: 34840068 DOI: 10.1016/j.drup.2021.100787] [Reference Citation Analysis]
13 Godel M, Ortone G, Anobile DP, Pasino M, Randazzo G, Riganti C, Kopecka J. Targeting Mitochondrial Oncometabolites: A New Approach to Overcome Drug Resistance in Cancer. Pharmaceutics 2021;13:762. [PMID: 34065551 DOI: 10.3390/pharmaceutics13050762] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Compton SLE, Grieco JP, Gollamudi B, Bae E, Van Mullekom JH, Schmelz EM. Metabolic Reprogramming of Ovarian Cancer Spheroids during Adhesion. Cancers (Basel) 2022;14:1399. [PMID: 35326551 DOI: 10.3390/cancers14061399] [Reference Citation Analysis]
15 Pandey A, Yadav P, Shukla S. Unfolding the role of autophagy in the cancer metabolism. Biochem Biophys Rep 2021;28:101158. [PMID: 34754952 DOI: 10.1016/j.bbrep.2021.101158] [Reference Citation Analysis]
16 Dabbagh N, Abbasvandi F, Miripour ZS, Hoseinpour P, Jahanbakhshi F, Moradi A, Riazi H, Moradian F, Zanjani FS, Parniani M, Akbari ME, Abdolahad M. Accuracy of cancer diagnostic probe for intra-surgical checking of cavity side margins in neoadjuvant breast cancer cases: A human model study. Int J Med Robot 2021;:e2335. [PMID: 34571582 DOI: 10.1002/rcs.2335] [Reference Citation Analysis]
17 Gonçalves AC, Richiardone E, Jorge J, Polónia B, Xavier CPR, Salaroglio IC, Riganti C, Vasconcelos MH, Corbet C, Sarmento-Ribeiro AB. Impact of cancer metabolism on therapy resistance - Clinical implications. Drug Resist Updat 2021;:100797. [PMID: 34955385 DOI: 10.1016/j.drup.2021.100797] [Reference Citation Analysis]
18 Imenez Silva PH, Câmara NO, Wagner CA. Role of proton-activated G protein-coupled receptors in pathophysiology. Am J Physiol Cell Physiol 2022. [PMID: 35759438 DOI: 10.1152/ajpcell.00114.2022] [Reference Citation Analysis]
19 Yoon N, Jang AK, Seo Y, Jung BH. Metabolomics in Autoimmune Diseases: Focus on Rheumatoid Arthritis, Systemic Lupus Erythematous, and Multiple Sclerosis. Metabolites 2021;11:812. [PMID: 34940570 DOI: 10.3390/metabo11120812] [Reference Citation Analysis]
20 Monferrer E, Vieco-Martí I, López-Carrasco A, Fariñas F, Abanades S, de la Cruz-Merino L, Noguera R, Álvaro Naranjo T. Metabolic Classification and Intervention Opportunities for Tumor Energy Dysfunction. Metabolites 2021;11:264. [PMID: 33922558 DOI: 10.3390/metabo11050264] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
21 Chiaradonna F, Scumaci D. Cancer Metabolism as a New Real Target in Tumor Therapy. Cells 2021;10:1393. [PMID: 34198722 DOI: 10.3390/cells10061393] [Reference Citation Analysis]
22 Khodaei T, Inamdar S, Suresh AP, Acharya AP. Drug delivery for metabolism targeted cancer immunotherapy. Adv Drug Deliv Rev 2022;184:114242. [PMID: 35367306 DOI: 10.1016/j.addr.2022.114242] [Reference Citation Analysis]
23 Sebestyén A, Kopper L, Dankó T, Tímár J. Hypoxia Signaling in Cancer: From Basics to Clinical Practice. Pathol Oncol Res 2021;27:1609802. [PMID: 34257622 DOI: 10.3389/pore.2021.1609802] [Reference Citation Analysis]
24 Gonzalez-molina J, Moyano-galceran L, Single A, Gultekin O, Alsalhi S, Lehti K. Chemotherapy as a regulator of extracellular matrix-cell communication: implications in therapy resistance. Seminars in Cancer Biology 2022. [DOI: 10.1016/j.semcancer.2022.03.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
25 El-Sayed NNE, Al-Otaibi TM, Alonazi M, Masand VH, Barakat A, Almarhoon ZM, Ben Bacha A. Synthesis and Characterization of Some New Quinoxalin-2(1H)one and 2-Methyl-3H-quinazolin-4-one Derivatives Targeting the Onset and Progression of CRC with SRA, Molecular Docking, and ADMET Analyses. Molecules 2021;26:3121. [PMID: 34071141 DOI: 10.3390/molecules26113121] [Reference Citation Analysis]
26 Ramtohul T, Tescher C, Vaflard P, Cyrta J, Girard N, Malhaire C, Tardivon A. Prospective Evaluation of Ultrafast Breast MRI for Predicting Pathologic Response after Neoadjuvant Therapies. Radiology 2022;:220389. [PMID: 35880977 DOI: 10.1148/radiol.220389] [Reference Citation Analysis]
27 Thévenod F, Schreiber T, Lee WK. Renal hypoxia-HIF-PHD-EPO signaling in transition metal nephrotoxicity: friend or foe? Arch Toxicol 2022. [PMID: 35445830 DOI: 10.1007/s00204-022-03285-3] [Reference Citation Analysis]